Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Capricor Therapeutics (CAPR) over the last 15 years, with Q3 2025 value amounting to $966329.0.

  • Capricor Therapeutics' Other Working Capital Changes rose 14272.69% to $966329.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$362423.0, marking a year-over-year increase of 9726.02%. This contributed to the annual value of -$12.3 million for FY2024, which is 28609.85% down from last year.
  • Latest data reveals that Capricor Therapeutics reported Other Working Capital Changes of $966329.0 as of Q3 2025, which was up 14272.69% from -$111096.0 recorded in Q2 2025.
  • In the past 5 years, Capricor Therapeutics' Other Working Capital Changes registered a high of $30.0 million during Q1 2022, and its lowest value of -$6.2 million during Q3 2023.
  • For the 5-year period, Capricor Therapeutics' Other Working Capital Changes averaged around $756693.3, with its median value being -$617377.0 (2021).
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first tumbled by 401804.7% in 2021, then soared by 1101500.49% in 2022.
  • Over the past 5 years, Capricor Therapeutics' Other Working Capital Changes (Quarter) stood at $881028.0 in 2021, then tumbled by 208.95% to -$959903.0 in 2022, then plummeted by 117.53% to -$2.1 million in 2023, then surged by 45.86% to -$1.1 million in 2024, then soared by 185.48% to $966329.0 in 2025.
  • Its last three reported values are $966329.0 in Q3 2025, -$111096.0 for Q2 2025, and -$87147.0 during Q1 2025.